<VariationArchive VariationID="575389" VariationName="NM_005859.5(PURA):c.494_497dup (p.Phe167fs)" VariationType="Duplication" Accession="VCV000575389" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="564833" VariationID="575389">
      <GeneList>
        <Gene Symbol="PURA" FullName="purine rich element binding protein A" GeneID="5813" HGNC_ID="HGNC:9701" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114109" stop="140125619" display_start="140114109" display_stop="140125619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139493707" stop="139499000" display_start="139493707" display_stop="139499000" Strand="+" />
          </Location>
          <OMIM>600473</OMIM>
          <Haploinsufficiency last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005859.5(PURA):c.494_497dup (p.Phe167fs)</Name>
      <CanonicalSPDI>NC_000005.10:140114672:CGGCCG:CGGCCGGCCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114672" stop="140114673" display_start="140114672" display_stop="140114673" variantLength="4" positionVCF="140114672" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139494257" stop="139494258" display_start="139494257" display_stop="139494258" variantLength="4" positionVCF="139494257" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
      </Location>
      <ProteinChange>F167fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.140114675_140114678dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.140114675_140114678dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.139494260_139494263dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.139494260_139494263dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041813.1" sequenceAccession="NG_041813" sequenceVersion="1" change="g.5553_5556dup">
            <Expression>NG_041813.1:g.5553_5556dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.5" sequenceAccession="NM_005859" sequenceVersion="5" change="c.494_497dup" MANESelect="true">
            <Expression>NM_005859.5:c.494_497dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005850.1" sequenceAccession="NP_005850" sequenceVersion="1" change="p.Phe167fs">
            <Expression>NP_005850.1:p.Phe167fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.4" sequenceAccession="NM_005859" sequenceVersion="4" change="c.494_497dupGCCG">
            <Expression>NM_005859.4:c.494_497dupGCCG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1561793268" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005859.5(PURA):c.494_497dup (p.Phe167fs) AND PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" Accession="RCV000697589" Version="6">
        <ClassifiedConditionList TraitSetID="20405">
          <ClassifiedCondition DB="MedGen" ID="C4015357">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25342064</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32585" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome</ElementValue>
                <XRef ID="MONDO:0018580" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600473.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDRIHF</ElementValue>
                <XRef Type="MIM" ID="616158" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurologic Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PURA-related neurodevelopmental disorders include PURA syndrome, caused by a heterozygous pathogenic sequence variant in PURA, and 5q31.3 deletion syndrome, caused by a genomic 5q31.3 deletion encompassing all or part of PURA.
PURA-related neurodevelopmental disorders are characterized by moderate-to-severe neurodevelopmental delay with absence of speech in most and lack of independent ambulation in many. Early-onset problems can include hypotonia, hypothermia, hypersomnolence, feeding difficulties, excessive hiccups, recurrent central and obstructive apneas, epileptic seizures, abnormal nonepileptic movements (dystonia, dyskinesia, and dysconjugate eye movements), and abnormal vision. Congenital heart defects, urogenital malformations, skeletal abnormalities, and endocrine disorders occur, but are less common.</Attribute>
                <XRef ID="NBK426063" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PURA-Related Neurodevelopmental Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28448108</ID>
                <ID Source="BookShelf">NBK426063</ID>
              </Citation>
              <XRef ID="438213" DB="Orphanet" />
              <XRef ID="438216" DB="Orphanet" />
              <XRef ID="C4015357" DB="MedGen" />
              <XRef Type="MIM" ID="616158" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1598026" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3947302|MedGen:C4015357" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000826209" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25342064</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe167Profs*35) in the PURA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 156 amino acid(s) of the PURA protein. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PURA protein in which other variant(s) (p.Glu283Argfs*45) have been determined to be pathogenic (PMID: 25342064). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 575389). This variant has not been reported in the literature in individuals affected with PURA-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.139494257_139494258insCGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4015357" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1598026" TraitType="Disease" MappingType="XRef" MappingValue="C4015357" MappingRef="MedGen">
        <MedGen CUI="C4015357" Name="PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

